Bagsværd, Denmark, 8 August 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.
Under the programme initiated 7 May 2019, Novo Nordisk has repurchased B shares for an amount up to DKK 2.7 billion in the period from 8 May 2019 to 7 August 2019. The programme is now concluded.
Since the announcement as of 5 August 2019, the following transactions have been made under the programme:
| Number of B shares | Average purchase price | Transaction value, DKK | |
| Accumulated, last announcement | 7,795,400 | 2,560,398,451 | |
| 5 August 2019 | 142,000 | 324.84 | 46,126,809 |
| 6 August 2019 | 116,080 | 323.32 | 37,531,075 |
| 7 August 2019 | 171,028 | 327.10 | 55,943,518 |
| Accumulated under the programme | 8,224,508 | 2,699,999,853 |
The details for each transaction made under the share repurchase programme are published on novonordisk.com.
With the transactions stated above, Novo Nordisk owns a total of 30,568,156 B shares of DKK 0.20, corresponding to 1.3% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 7 August 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 23,401,012 B shares at an average share price of DKK 326.27 per B share equal to a transaction value of DKK 7,634,953,454.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
| Ken Inchausti (US) | +1 609 240 9429 | kiau@novonordisk.com |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
| Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com |
| Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com |
| Kristoffer Due Berg (US) | +1 609 235 2989 | krdb@novonordisk.com |
Attachment
